195 related articles for article (PubMed ID: 19267183)
1. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
Groves MD; Hess KR; Puduvalli VK; Colman H; Conrad CA; Gilbert MR; Weinberg J; Cristofanilli M; Yung WK; Liu TJ
J Neurooncol; 2009 Sep; 94(2):229-34. PubMed ID: 19267183
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
[TBL] [Abstract][Full Text] [Related]
3. Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis.
Shingyoji M; Kageyama H; Sakaida T; Nakajima T; Matsui Y; Itakura M; Iuchi T; Yokoi S; Kimura H; Iizasa T
J Thorac Oncol; 2011 Jul; 6(7):1215-20. PubMed ID: 21610522
[TBL] [Abstract][Full Text] [Related]
4. Malignant meningitis: a rational approach to cerebrospinal fluid cytology.
MacKenzie JM
J Clin Pathol; 1996 Jun; 49(6):497-9. PubMed ID: 8763266
[TBL] [Abstract][Full Text] [Related]
5. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
[TBL] [Abstract][Full Text] [Related]
6. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.
Le Rhun E; Taillibert S; Chamberlain MC
Cancer Control; 2017 Jan; 24(1):22-32. PubMed ID: 28178709
[TBL] [Abstract][Full Text] [Related]
8. Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer.
Economidou F; Antoniou KM; Soufla G; Lasithiotaki I; Karagiannis K; Lymbouridou R; Proklou A; Spandidos DA; Siafakas NM
J Recept Signal Transduct Res; 2010 Jun; 30(3):154-60. PubMed ID: 20196627
[TBL] [Abstract][Full Text] [Related]
9. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
Chamberlain MC
Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
[TBL] [Abstract][Full Text] [Related]
10. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V
Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis.
Chamberlain MC
Cancer; 2002 May; 94(10):2675-80. PubMed ID: 12173336
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
[TBL] [Abstract][Full Text] [Related]
15. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid (vascular endothelial growth factor) and serologic (recoverin) tumor markers for malignant glioma.
Sampath P; Weaver CE; Sungarian A; Cortez S; Alderson L; Stopa EG
Cancer Control; 2004; 11(3):174-80. PubMed ID: 15153841
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
Cancer; 1992 Mar; 69(6):1475-80. PubMed ID: 1371713
[TBL] [Abstract][Full Text] [Related]
18. Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system.
Ehya H; Hajdu SI; Melamed MR
Acta Cytol; 1981; 25(6):599-610. PubMed ID: 6947665
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
Sonmez K; Drenser KA; Capone A; Trese MT
Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Wang Q; Diao X; Sun J; Chen Z
Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
